BioVie announced that the Company will be added as a member of the US small-cap Russell 2000 and Russell 3000 Indexes, effective after the US market opens on June 26, as part of the 2023 Russell indexes reconstitution. Membership in the Russell 2000(R) Index, which remains in place for one year, is based on membership in the broad-market Russell 3000 Index. The stock also was automatically added to the appropriate growth and value indexes.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on BIVI:
- BioVie Set to Join the Russell 2000® and Russell 3000® Indexes
- Cantor Fitzgerald healthcare analyst holds an analyst/industry conference call
- BioVie to present data from its Phase 3 study of NE3107
- BioVie To Present of NE3017 in Alzheimer’s Disease Data at 83rd Scientific Sessions of the American Diabetes Association
- BioVie Presents Rationale for Potentially Pivotal Trial of NE3107 in the Treatment of Parkinson’s Disease at 2023 International Association of Parkinsonism and Related Disorders World Congress